Gschwendt M - Search Results

1

Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro.

Gschwendt M, Fürstenberger G, Rose-John S, Rogers M, Kittstein W, Pettit GR, Herald CL, Marks F. Gschwendt M, et al. Carcinogenesis. 1988 Apr;9(4):555-62. doi: 10.1093/carcin/9.4.555. Carcinogenesis. 1988. PMID: 2451575

2

Protein kinase C activation by phorbol esters: do cysteine-rich regions and pseudosubstrate motifs play a role?

Gschwendt M, Kittstein W, Marks F. Gschwendt M, et al. Trends Biochem Sci. 1991 May;16(5):167-9. doi: 10.1016/0968-0004(91)90064-3. Trends Biochem Sci. 1991. PMID: 1820763 Review.

3

Down-regulation of protein kinase C in Swiss 3T3 fibroblasts is independent of its phosphorylating activity.

Lindner D, Gschwendt M, Marks F. Lindner D, et al. Among authors: gschwendt m. Biochem Biophys Res Commun. 1991 May 15;176(3):1227-31. doi: 10.1016/0006-291x(91)90416-5. Biochem Biophys Res Commun. 1991. PMID: 2039508

4

The immunosuppressant FK-506, like cyclosporins and didemnin B, inhibits calmodulin-dependent phosphorylation of the elongation factor 2 in vitro and biological effects of the phorbol ester TPA on mouse skin in vivo.

Gschwendt M, Kittstein W, Marks F. Gschwendt M, et al. Immunobiology. 1989 Mar;179(1):1-7. doi: 10.1016/s0171-2985(89)80002-6. Immunobiology. 1989. PMID: 2471685

5

A type 2A protein phosphatase dephosphorylates the elongation factor 2 and is stimulated by the phorbol ester TPA in mouse epidermis in vivo.

Gschwendt M, Kittstein W, Mieskes G, Marks F. Gschwendt M, et al. FEBS Lett. 1989 Nov 6;257(2):357-60. doi: 10.1016/0014-5793(89)81571-6. FEBS Lett. 1989. PMID: 2555220 Free article.

6

Cyclosporine A suppresses an early process in phorbol ester action.

Gschwendt M, Kittstein W, Marks F. Gschwendt M, et al. Cancer Lett. 1989 Jul 15;46(2):113-5. doi: 10.1016/0304-3835(89)90017-7. Cancer Lett. 1989. PMID: 2752381

7

Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1H-n.m.r. and GC-MS spectroscopy.

Gschwendt M, Fürstenberger G, Kittstein W, Besemfelder E, Hull WE, Hagedorn H, Opferkuch HJ, Marks F. Gschwendt M, et al. Carcinogenesis. 1986 Mar;7(3):449-55. doi: 10.1093/carcin/7.3.449. Carcinogenesis. 1986. PMID: 3081276

8

Ciclosporin inhibits phorbol-ester-induced hyperplastic transformation and tumor promotion in mouse skin probably by suppression of Ca2+/calmodulin-dependent processes such as phosphorylation of elongation factor 2.

Gschwendt M, Kittstein W, Marks F. Gschwendt M, et al. Skin Pharmacol. 1988;1(2):84-92. doi: 10.1159/000210753. Skin Pharmacol. 1988. PMID: 3273203

9

The weak immunosuppressant cyclosporine D as well as the immunologically inactive cyclosporine H are potent inhibitors in vivo of phorbol ester TPA-induced biological effects in mouse skin and of Ca2+/calmodulin dependent EF-2 phosphorylation in vitro.

Gschwendt M, Kittstein W, Marks F. Gschwendt M, et al. Biochem Biophys Res Commun. 1988 Jan 29;150(2):545-51. doi: 10.1016/0006-291x(88)90428-7. Biochem Biophys Res Commun. 1988. PMID: 3342035

10

Effect of tumor promoting phorbol ester TPA on epidermal protein synthesis: stimulation of an elongation factor 2 phosphatase activity by TPA in vivo.

Gschwendt M, Kittstein W, Marks F. Gschwendt M, et al. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1129-35. doi: 10.1016/s0006-291x(88)81345-7. Biochem Biophys Res Commun. 1988. PMID: 3390175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters